Xiaobi Huang

440 total citations
17 papers, 113 citations indexed

About

Xiaobi Huang is a scholar working on Molecular Biology, Cancer Research and Hepatology. According to data from OpenAlex, Xiaobi Huang has authored 17 papers receiving a total of 113 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Hepatology. Recurrent topics in Xiaobi Huang's work include Cancer-related molecular mechanisms research (5 papers), Hepatitis C virus research (5 papers) and RNA modifications and cancer (4 papers). Xiaobi Huang is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Hepatitis C virus research (5 papers) and RNA modifications and cancer (4 papers). Xiaobi Huang collaborates with scholars based in United States, China and Spain. Xiaobi Huang's co-authors include Zhuwen Wang, Lei Zou, Zhixiong Yang, Feiyu Niu, Lihui Wang, Chunfang Guo, Xia Yang, Xiao Yang, Guoan Chen and Wenmei Su and has published in prestigious journals such as Neurology, Annals of the Rheumatic Diseases and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Xiaobi Huang

16 papers receiving 112 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaobi Huang United States 5 40 39 35 21 17 17 113
Barbara Moszczuk Poland 6 37 0.9× 18 0.5× 8 0.2× 23 1.1× 20 1.2× 12 111
Guy Rosner Israel 8 40 1.0× 31 0.8× 76 2.2× 45 2.1× 66 3.9× 19 212
Rüveyda Ayasun United States 6 47 1.2× 24 0.6× 11 0.3× 57 2.7× 22 1.3× 10 165
Sumera Rizvi United States 4 34 0.8× 16 0.4× 13 0.4× 24 1.1× 13 0.8× 12 142
Ruth Gershoni Baruch Israel 6 121 3.0× 21 0.5× 17 0.5× 15 0.7× 6 0.4× 8 199
Fuai Lu China 5 74 1.9× 20 0.5× 11 0.3× 8 0.4× 12 0.7× 6 172
Emily R. Soper United States 7 64 1.6× 38 1.0× 47 1.3× 24 1.1× 22 1.3× 13 195
Lucy Lim Australia 6 26 0.7× 15 0.4× 10 0.3× 32 1.5× 42 2.5× 7 122
Jip Ramaker Netherlands 6 76 1.9× 93 2.4× 17 0.5× 18 0.9× 12 0.7× 9 155
Lauren E. Wiznia United States 8 20 0.5× 15 0.4× 22 0.6× 33 1.6× 41 2.4× 15 137

Countries citing papers authored by Xiaobi Huang

Since Specialization
Citations

This map shows the geographic impact of Xiaobi Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobi Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobi Huang more than expected).

Fields of papers citing papers by Xiaobi Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobi Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobi Huang. The network helps show where Xiaobi Huang may publish in the future.

Co-authorship network of co-authors of Xiaobi Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobi Huang. A scholar is included among the top collaborators of Xiaobi Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobi Huang. Xiaobi Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Huang, Xiaobi, Xiaofang Li, Yongyang Chen, et al.. (2024). Suppression of the long non-coding RNA LINC01279 triggers autophagy and apoptosis in lung cancer by regulating FAK and SIN3A. Discover Oncology. 15(1). 3–3. 5 indexed citations
3.
Huang, Xiaobi, et al.. (2024). Silencing of the long non-coding RNA <i>LINC00265</i> triggers autophagy and apoptosis in lung cancer by reducing protein stability of SIN3A oncogene. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 32(7). 1185–1195. 2 indexed citations
4.
Chen, Yongyang, Xiaobi Huang, Lihui Wang, et al.. (2023). Circular RNA‐mediated ceRNA network was identified in human lung adenocarcinoma by high‐throughput sequencing. Thoracic Cancer. 14(16). 1430–1439. 4 indexed citations
5.
Coles, Alasdair, Douglas L. Arnold, Ann Bass, et al.. (2021). Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial. Therapeutic Advances in Neurological Disorders. 14. 1279203702–1279203702. 34 indexed citations
6.
Huang, Zhong, et al.. (2020). <p>The Clinical Characteristics and Prognosis of Different Age Patients with Lung Cancer</p>. Cancer Management and Research. Volume 12. 8445–8450. 2 indexed citations
7.
Su, Wenmei, Chunfang Guo, Lihui Wang, et al.. (2019). LncRNA MIR22HG abrogation inhibits proliferation and induces apoptosis in esophageal adenocarcinoma cells via activation of the STAT3/c-Myc/FAK signaling. Aging. 11(13). 4587–4596. 36 indexed citations
8.
9.
10.
Feng, Hwa-ping, Zifang Guo, Lisa Ross, et al.. (2018). Assessment of drug interaction potential between the HCV direct-acting antiviral agents elbasvir/grazoprevir and the HIV integrase inhibitors raltegravir and dolutegravir. Journal of Antimicrobial Chemotherapy. 74(3). 710–717. 4 indexed citations
11.
12.
Marshall, William L., Larissa Wenning, Xiaobi Huang, et al.. (2017). Pharmacokinetics, Safety, and Tolerability of Single-Dose Elbasvir in Participants with Hepatic Impairment. European Journal of Drug Metabolism and Pharmacokinetics. 43(3). 321–329. 4 indexed citations
13.
Marshall, William L., Hwa-ping Feng, Luzelena Caro, et al.. (2017). No clinically meaningful pharmacokinetic interaction between the hepatitis C virus inhibitors elbasvir and grazoprevir and the oral contraceptives ethinyl estradiol and levonorgestrel. European Journal of Clinical Pharmacology. 73(5). 593–600. 7 indexed citations
14.
González, Rafael Arroyo, David Margolin, Xiaobi Huang, et al.. (2017). Improvements in Quality of Life Over 6 Years in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Alemtuzumab: Results From the CARE-MS II Extension Study (P5.342). Neurology. 88(16_supplement). 2 indexed citations
15.
Huang, Xiaobi. (2016). A Simulation Study to Decide the Timing of an Interim Analysis in a Bayesian Adaptive Dose-Finding Studies with Delayed Responses. Biometrics & Biostatistics International Journal. 3(6). 2 indexed citations
16.
Mangin, Eric, Wendy W. Yeh, Luzelena Caro, et al.. (2013). Safety and pharmacokinetics of single and multiple oral doses of MK-8742, an HCV NS5A inhibitor, in healthy subjects. Ghent University Academic Bibliography (Ghent University). 3 indexed citations
17.
Huang, Xiaobi, Michael R. Elliott, & Sioḃán D. Harlow. (2013). Modelling Menstrual Cycle Length and Variability at the Approach of Menopause by Using Hierarchical Change Point Models. Journal of the Royal Statistical Society Series C (Applied Statistics). 63(3). 445–466. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara Moszczuk Breakdown of academic impact, for papers by Guy Rosner Breakdown of academic impact, for papers by Rüveyda Ayasun Breakdown of academic impact, for papers by Sumera Rizvi Breakdown of academic impact, for papers by Ruth Gershoni Baruch Breakdown of academic impact, for papers by Fuai Lu Breakdown of academic impact, for papers by Emily R. Soper Breakdown of academic impact, for papers by Lucy Lim Breakdown of academic impact, for papers by Jip Ramaker Breakdown of academic impact, for papers by Lauren E. Wiznia
Rankless by CCL
2026